Wegovy

Wegovy (semaglutide) is a prescription medication specifically developed to support weight loss and long-term weight management in adults who are obese or overweight and have at least one weight-related health condition.

The active ingredient, semaglutide, works by mimicking a natural hormone called glucagon-like peptide-1 (GLP-1) which helps regulate appetite and blood sugar levels, making it easier to follow a reduced calorie diet and achieve meaningful weight loss. Wegovy is administered once a week as a subcutaneous injection and is most effective when combined with increased physical activity and healthy lifestyle changes. By helping to reduce hunger and promote feelings of fullness, Wegovy can play a key role in helping patients reach and maintain a healthier weight.

Weight Loss Trial Highlights

The “Step Up” trial, a randomized, double-blind study presented at the American Diabetes Association (ADA) scientific sessions in Chicago, involved 1,407 adults with a BMI of 30 kg/m² or higher, without diabetes. In this trial, the Wegovy dosage was carefully selected and adjusted for each participant to ensure the best dosage for weight loss and safety, following the doctor’s recommendation. Over 72 weeks, participants receiving the 7.2mg weekly injection achieved an average weight reduction of 20.7% of their body weight. Notably, one-third of participants lost at least 25% of their body weight, compared to a 17.5% reduction with the 2.4mg dose and just 2.4% with a placebo. The doctor determines the appropriate Wegovy dose for each patient, and the doctor prescribes the medication based on individual needs. Wegovy is intended as a long term treatment to help patients lose weight and maintain their results.

During the trial, the Wegovy dose was slowly increased under a doctor’s recommendation to minimize side effects and ensure patient safety. When comparing the 7.2mg and 2.4mg doses, the lower dose was less effective, and doctors may prescribe Wegovy at different strengths depending on patient response. It is important to always follow the doctor’s recommendations when adjusting Wegovy’s dosage.

Dosage and Administration

Wegovy’s dosage is carefully structured to maximize effectiveness while minimizing side effects. Treatment typically begins with a starting dose of 0.25 mg once weekly, followed by a gradual dose escalation schedule. Over several weeks, the dose is slowly increased until reaching the maintenance dose, which is usually 2.4 mg or, in some cases, 1.7 mg per week. This stepwise approach helps the body adjust to the medication and reduces the likelihood of gastrointestinal side effects. Wegovy is supplied in prefilled pens, making it easy to inject at home. It’s important to rotate the injection site, choosing between the abdomen, thigh, or upper arm, with each dose to prevent irritation. Patients should always follow their healthcare provider’s dosing schedule and recommendations to ensure the best results from their treatment.

Dosing Schedule and Missed Dose

Wegovy is designed to be taken once a week, ideally on the same day and at the same time each week to maintain consistent levels in the body. If a scheduled dose is missed, patients should refer to their healthcare provider’s instructions:

• If the next scheduled dose is more than 48 hours away, the missed dose should be taken as soon as possible.
• If less than 48 hours remain until the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed.

It’s important not to take extra doses to make up for a missed one. For any questions about missed doses or adjustments to the treatment plan, patients should consult their healthcare provider to ensure safe and effective weight management.